Home » Topics » Regulatory » NMPA

NMPA
RSS

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Aug. 18, 2016

Cervarix approved in China

July 18, 2016

CFDA approves Roche's CINtec PLUS Cytology test

March 9, 2016

3SBio obtains IND clearance in China for PEG-irinotecan

March 7, 2016

Tapros approved for open-angle glaucoma and ocular hypertension in China

Aug. 26, 2015

CFDA approves phase I/II/III clinical trials of pirotinib

Aug. 14, 2015

China Food and Drug Administration accepts clinical trial application for sirotinib

July 16, 2015

Phase II trials of F-351 begin in China

June 12, 2015

Arteether amine maleate cleared to enter clinical studies in China

May 26, 2015

China FDA clears IND for development of DP-VPA through phase III for epilepsy

April 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.